|
JP5693951B2
(ja)
|
2007-04-24 |
2015-04-01 |
アストラゼネカ エービー |
プロテインキナーゼの阻害剤
|
|
JP5566880B2
(ja)
*
|
2007-04-24 |
2014-08-06 |
インゲニウム ファーマシューティカルズ ジーエムビーエイチ |
プロテインキナーゼの阻害剤としての４，６−二置換アミノピリミジン誘導体
|
|
JP5566879B2
(ja)
*
|
2007-04-24 |
2014-08-06 |
インゲニウム ファーマシューティカルズ ジーエムビーエイチ |
プロテインキナーゼの阻害剤
|
|
WO2011003236A1
(zh)
*
|
2009-07-08 |
2011-01-13 |
乔志亚生技股份有限公司 |
一种龙眼核萃取物的制备方法与应用
|
|
JP2013107824A
(ja)
*
|
2010-03-17 |
2013-06-06 |
Dainippon Sumitomo Pharma Co Ltd |
新規単環ピリミジン誘導体
|
|
JP5921525B2
(ja)
*
|
2010-03-22 |
2016-05-24 |
リード ディスカバリー センター ゲゼルシャフト ミット ベシュレンクテル ハフツング |
医薬的に活性のある二置換のトリアジン誘導体
|
|
WO2012066065A1
(en)
*
|
2010-11-17 |
2012-05-24 |
Novartis Ag |
Phenyl-heteroaryl amine compounds and their uses
|
|
WO2012117048A1
(en)
|
2011-03-02 |
2012-09-07 |
Lead Discovery Center Gmbh |
Pharmaceutically active disubstituted triazine derivatives
|
|
ES2567066T3
(es)
*
|
2011-03-02 |
2016-04-19 |
Lead Discovery Center Gmbh |
Derivados de piridina disustituida farmacéuticamente activos
|
|
KR20140019381A
(ko)
*
|
2011-04-19 |
2014-02-14 |
바이엘 인텔렉쳐 프로퍼티 게엠베하 |
치환된 4-아릴-n-페닐-1,3,5-트리아진-2-아민
|
|
TW201636330A
(zh)
|
2011-05-24 |
2016-10-16 |
拜耳知識產權公司 |
含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
|
|
EP2527332A1
(en)
|
2011-05-24 |
2012-11-28 |
Bayer Intellectual Property GmbH |
4-Aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group as CDK9 inhibitors
|
|
CA2848616A1
(en)
*
|
2011-09-16 |
2013-03-21 |
Bayer Intellectual Property Gmbh |
Disubstituted 5-fluoro-pyrimidines
|
|
WO2013037894A1
(en)
|
2011-09-16 |
2013-03-21 |
Bayer Intellectual Property Gmbh |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
|
|
ES2595222T3
(es)
*
|
2012-10-18 |
2016-12-28 |
Bayer Pharma Aktiengesellschaft |
Derivados de 5-fluoro-N-(piridin-2-il)piridin-2-amina que contienen un grupo sulfona
|
|
CN105283453B
(zh)
|
2012-10-18 |
2018-06-22 |
拜耳药业股份公司 |
含砜基的n-(吡啶-2-基)嘧啶-4-胺衍生物
|
|
US20150259300A1
(en)
*
|
2012-10-18 |
2015-09-17 |
Bayer Pharma Aktiengesellschaft |
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfone group
|
|
ES2622583T3
(es)
*
|
2012-11-15 |
2017-07-06 |
Bayer Pharma Aktiengesellschaft |
4-(Orto)-fluorofenil-5-fluoropirimidin-2-ilaminas que contienen un grupo sulfoximina
|
|
US9650340B2
(en)
|
2012-11-15 |
2017-05-16 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
|
|
TW201418243A
(zh)
|
2012-11-15 |
2014-05-16 |
Bayer Pharma AG |
含有磺醯亞胺基團之ｎ－（吡啶－２－基）嘧啶－４－胺衍生物
|
|
US9770445B2
(en)
|
2013-07-04 |
2017-09-26 |
Bayer Pharma Aktiengesellschaft |
Sulfoximine substituted 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives and their use as CDK9 kinase inhibitors
|
|
CA2942119A1
(en)
|
2014-03-13 |
2015-09-17 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
EP3126338B1
(en)
|
2014-04-01 |
2019-09-04 |
Bayer Pharma Aktiengesellschaft |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
|
|
CR20160471A
(es)
|
2014-04-11 |
2016-12-21 |
Bayer Pharma AG |
Compuestos novedosos macrocíclicos
|
|
CN107207475A
(zh)
|
2014-10-16 |
2017-09-26 |
拜耳医药股份有限公司 |
含有砜基团的氟化苯并呋喃基‑嘧啶衍生物
|
|
EP3207038B1
(en)
|
2014-10-16 |
2018-08-22 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
|
|
WO2016150902A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating gastric cancers
|
|
CA2980493A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating multiple myeloma
|
|
CA2980507A1
(en)
|
2015-03-24 |
2016-09-29 |
Public University Corporation Nagoya City University |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating lymphomas
|
|
ES2902148T3
(es)
|
2015-06-29 |
2022-03-25 |
Astrazeneca Ab |
Derivados de amidas policíclicas como inhibidores de CDK9
|
|
JP6847099B2
(ja)
|
2015-09-29 |
2021-03-24 |
バイエル ファーマ アクチエンゲゼルシャフト |
新規な大環状スルホンジイミン化合物
|
|
CN108368129B
(zh)
|
2015-10-08 |
2021-08-17 |
拜耳医药股份有限公司 |
改性大环化合物
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
EP3601253B1
(en)
|
2017-03-28 |
2021-09-15 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
WO2018177889A1
(en)
|
2017-03-28 |
2018-10-04 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
KR102764122B1
(ko)
|
2018-02-13 |
2025-02-05 |
바이엘 악티엔게젤샤프트 |
미만성 거대 b-세포 림프종을 치료하기 위한 5-플루오로-4-(4-플루오로-2-메톡시페닐)-n-[4-[(s-메틸술폰이미도일)메틸]피리딘-2-일]피리딘-2-아민의 용도
|
|
CN115335058B
(zh)
*
|
2020-03-27 |
2024-12-06 |
国立大学法人京都大学 |
神经细胞变性抑制剂
|